Skip to main content
Top
Published in: BMC Cancer 1/2021

Open Access 01-12-2021 | Computed Tomography | Research article

Development and validation of nomograms to intraoperatively predict metastatic patterns in regional lymph nodes in patients diagnosed with esophageal cancer

Authors: Fei Zhao, Rong-Xin Lu, Jin-Yuan Liu, Jun Fan, Hao-Ran Lin, Xiao-Yu Yang, Shu-Hui You, Qian-Ge Wu, Xue-Yun Qin, Yi Liu, Fu-Xi Zhen, Jin-Hua Luo, Wei Wang

Published in: BMC Cancer | Issue 1/2021

Login to get access

Abstract

Background

An accurate intraoperative prediction of lymph node metastatic risk can help surgeons in choosing precise surgical procedures. We aimed to develop and validate nomograms to intraoperatively predict patterns of regional lymph node (LN) metastasis in patients with esophageal cancer.

Methods

The prediction model was developed in a training cohort consisting of 487 patients diagnosed with esophageal cancer who underwent esophagectomy with complete LN dissection from January 2016 to December 2016. Univariate and multivariable logistic regression were used to identify independent risk factors that were incorporated into a prediction model and used to construct a nomogram. Contrast-enhanced computed tomography reported LN status and was an important comparative factor of clinical usefulness in a validation cohort. Nomogram performance was assessed in terms of calibration, discrimination, and clinical usefulness. An independent validation cohort comprised 206 consecutive patients from January 2017 to December 2017.

Results

Univariate analysis and multivariable logistic regression revealed three independent predictors of metastatic regional LNs, three independent predictors of continuous regional LNs, and two independent predictors of skipping regional LNs. Independent predictors were used to build three individualized prediction nomograms. The models showed good calibration and discrimination, with area under the curve (AUC) values of 0.737, 0.738, and 0.707. Application of the nomogram in the validation cohort yielded good calibration and discrimination, with AUC values of 0.728, 0.668, and 0.657. Decision curve analysis demonstrated that the three nomograms were clinically useful in the validation cohort.

Conclusion

This study presents three nomograms that incorporate clinicopathologic factors, which can be used to facilitate the intraoperative prediction of metastatic regional LN patterns in patients with esophageal cancer.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86.PubMedCrossRef Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86.PubMedCrossRef
2.
go back to reference Kayani B, Zacharakis E, Ahmed K, Hanna GB. Lymph node metastases and prognosis in oesophageal carcinoma--a systematic review. Eur J Surg Oncol. 2011;37(9):747–53.PubMedCrossRef Kayani B, Zacharakis E, Ahmed K, Hanna GB. Lymph node metastases and prognosis in oesophageal carcinoma--a systematic review. Eur J Surg Oncol. 2011;37(9):747–53.PubMedCrossRef
3.
go back to reference Kumakura Y, Yokobori T, Yoshida T, Hara K, Sakai M, Sohda M, et al. Elucidation of the anatomical mechanism of nodal skip metastasis in superficial thoracic esophageal squamous cell carcinoma. Ann Surg Oncol. 2018;25(5):1221–8.PubMedPubMedCentralCrossRef Kumakura Y, Yokobori T, Yoshida T, Hara K, Sakai M, Sohda M, et al. Elucidation of the anatomical mechanism of nodal skip metastasis in superficial thoracic esophageal squamous cell carcinoma. Ann Surg Oncol. 2018;25(5):1221–8.PubMedPubMedCentralCrossRef
4.
go back to reference Hofstetter W. Treatment of clinical T2N0M0 esophageal cancer. Ann Surg Oncol. 2014;21(12):3713–4.PubMedCrossRef Hofstetter W. Treatment of clinical T2N0M0 esophageal cancer. Ann Surg Oncol. 2014;21(12):3713–4.PubMedCrossRef
5.
go back to reference Speicher PJ, Ganapathi AM, Englum BR, Hartwig MG, Onaitis MW, D'Amico TA, et al. Induction therapy does not improve survival for clinical stage T2N0 esophageal cancer. J Thorac Oncol. 2014;9(8):1195–201.PubMedPubMedCentralCrossRef Speicher PJ, Ganapathi AM, Englum BR, Hartwig MG, Onaitis MW, D'Amico TA, et al. Induction therapy does not improve survival for clinical stage T2N0 esophageal cancer. J Thorac Oncol. 2014;9(8):1195–201.PubMedPubMedCentralCrossRef
6.
go back to reference Choi JY, Lee KH, Shim YM, Lee KS, Kim JJ, Kim SE, et al. Improved detection of individual nodal involvement in squamous cell carcinoma of the esophagus by FDG PET. J Nucl Med. 2000;41(5):808–15.PubMed Choi JY, Lee KH, Shim YM, Lee KS, Kim JJ, Kim SE, et al. Improved detection of individual nodal involvement in squamous cell carcinoma of the esophagus by FDG PET. J Nucl Med. 2000;41(5):808–15.PubMed
7.
go back to reference Yoon YC, Lee KS, Shim YM, Kim BT, Kim K, Kim TS. Metastasis to regional lymph nodes in patients with esophageal squamous cell carcinoma: CT versus FDG PET for presurgical detection prospective study. Radiology. 2003;227(3):764–70.PubMedCrossRef Yoon YC, Lee KS, Shim YM, Kim BT, Kim K, Kim TS. Metastasis to regional lymph nodes in patients with esophageal squamous cell carcinoma: CT versus FDG PET for presurgical detection prospective study. Radiology. 2003;227(3):764–70.PubMedCrossRef
8.
go back to reference Devadas M, Mittal A, Lin M, Cosman P, Ziazaris W, Wilson R, et al. FDG-PET nodal staging does not correlate with histopathological nodal stage for oesophageal cancers. Int J Surg. 2015;20:113–7.PubMedCrossRef Devadas M, Mittal A, Lin M, Cosman P, Ziazaris W, Wilson R, et al. FDG-PET nodal staging does not correlate with histopathological nodal stage for oesophageal cancers. Int J Surg. 2015;20:113–7.PubMedCrossRef
9.
go back to reference Foley KG, Lewis WG, Fielding P, Karran A, Chan D, Blake P, et al. N-staging of oesophageal and junctional carcinoma: is there still a role for EUS in patients staged N0 at PET/CT? Clin Radiol. 2014;69(9):959–64.PubMedCrossRef Foley KG, Lewis WG, Fielding P, Karran A, Chan D, Blake P, et al. N-staging of oesophageal and junctional carcinoma: is there still a role for EUS in patients staged N0 at PET/CT? Clin Radiol. 2014;69(9):959–64.PubMedCrossRef
10.
go back to reference Wang ZQ, Deng HY, Hu Y, Yuan Y, Wang WP, Wang YC, et al. Prognostic value of right upper mediastinal lymphadenectomy in sweet procedure for esophageal cancer. J Thorac Dis. 2016;8(12):3625–32.PubMedPubMedCentralCrossRef Wang ZQ, Deng HY, Hu Y, Yuan Y, Wang WP, Wang YC, et al. Prognostic value of right upper mediastinal lymphadenectomy in sweet procedure for esophageal cancer. J Thorac Dis. 2016;8(12):3625–32.PubMedPubMedCentralCrossRef
11.
go back to reference Hsu PK, Huang CS, Hsieh CC, Wu YC, Hsu WH. Role of right upper mediastinal lymph node metastasis in patients with esophageal squamous cell carcinoma after tri-incisional esophagectomies. Surgery. 2014;156(5):1269–77.PubMedCrossRef Hsu PK, Huang CS, Hsieh CC, Wu YC, Hsu WH. Role of right upper mediastinal lymph node metastasis in patients with esophageal squamous cell carcinoma after tri-incisional esophagectomies. Surgery. 2014;156(5):1269–77.PubMedCrossRef
13.
go back to reference Yachida T, Oda I, Abe S, Sekiguchi M, Nonaka S, Suzuki H, et al. Risk of lymph node metastasis in patients with the superficial spreading type of esophageal squamous cell carcinoma. Digestion. 2020;101(3):239–44. Yachida T, Oda I, Abe S, Sekiguchi M, Nonaka S, Suzuki H, et al. Risk of lymph node metastasis in patients with the superficial spreading type of esophageal squamous cell carcinoma. Digestion. 2020;101(3):239–44.
14.
go back to reference Min BH, Yang JW, Min YW, Baek SY, Kim S, Kim HK, et al. Nomogram for prediction of lymph node metastasis in patients with superficial esophageal squamous cell carcinoma. J Gastroenterol Hepatol. 2020;35(6):1009–15. Min BH, Yang JW, Min YW, Baek SY, Kim S, Kim HK, et al. Nomogram for prediction of lymph node metastasis in patients with superficial esophageal squamous cell carcinoma. J Gastroenterol Hepatol. 2020;35(6):1009–15.
15.
go back to reference Liu Y, Zou ZQ, Xiao J, Zhang M, Yuan L, Zhao XG. A nomogram prediction model for recurrent laryngeal nerve lymph node metastasis in thoracic oesophageal squamous cell carcinoma. J Thorac Dis. 2019;11(7):2868–77.PubMedPubMedCentralCrossRef Liu Y, Zou ZQ, Xiao J, Zhang M, Yuan L, Zhao XG. A nomogram prediction model for recurrent laryngeal nerve lymph node metastasis in thoracic oesophageal squamous cell carcinoma. J Thorac Dis. 2019;11(7):2868–77.PubMedPubMedCentralCrossRef
16.
go back to reference Nicholson AG, Tsao MS, Travis WD, Patil DT, Galateau-Salle F, Marino M, et al. Eighth edition staging of thoracic malignancies: implications for the reporting pathologist. Arch Pathol Lab Med. 2018;142(5):645–61.PubMedCrossRef Nicholson AG, Tsao MS, Travis WD, Patil DT, Galateau-Salle F, Marino M, et al. Eighth edition staging of thoracic malignancies: implications for the reporting pathologist. Arch Pathol Lab Med. 2018;142(5):645–61.PubMedCrossRef
17.
go back to reference Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, et al. The eighth edition AJCC Cancer staging manual: continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging. CA Cancer J Clin. 2017;67(2):93–9.PubMedCrossRef Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, et al. The eighth edition AJCC Cancer staging manual: continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging. CA Cancer J Clin. 2017;67(2):93–9.PubMedCrossRef
18.
19.
go back to reference Li B, Chen H, Xiang J, Zhang Y, Li C, Hu H, et al. Pattern of lymphatic spread in thoracic esophageal squamous cell carcinoma: a single-institution experience. J Thorac Cardiovasc Surg. 2012;144(4):778–85 discussion 85-6.PubMedCrossRef Li B, Chen H, Xiang J, Zhang Y, Li C, Hu H, et al. Pattern of lymphatic spread in thoracic esophageal squamous cell carcinoma: a single-institution experience. J Thorac Cardiovasc Surg. 2012;144(4):778–85 discussion 85-6.PubMedCrossRef
20.
go back to reference Prenzel KL, Bollschweiler E, Schroder W, Monig SP, Drebber U, Vallboehmer D, et al. Prognostic relevance of skip metastases in esophageal cancer. Ann Thorac Surg. 2010;90(5):1662–7.PubMedCrossRef Prenzel KL, Bollschweiler E, Schroder W, Monig SP, Drebber U, Vallboehmer D, et al. Prognostic relevance of skip metastases in esophageal cancer. Ann Thorac Surg. 2010;90(5):1662–7.PubMedCrossRef
21.
go back to reference Booka E, Takeuchi H, Nishi T, Matsuda S, Kaburagi T, Fukuda K, et al. The impact of postoperative complications on survivals after Esophagectomy for esophageal Cancer. Medicine (Baltimore). 2015;94(33):e1369.CrossRef Booka E, Takeuchi H, Nishi T, Matsuda S, Kaburagi T, Fukuda K, et al. The impact of postoperative complications on survivals after Esophagectomy for esophageal Cancer. Medicine (Baltimore). 2015;94(33):e1369.CrossRef
22.
go back to reference Shang QX, Chen LQ, Hu WP, Deng HY, Yuan Y, Cai J. Three-field lymph node dissection in treating the esophageal cancer. J Thorac Dis. 2016;8(10):E1136–E49.PubMedPubMedCentralCrossRef Shang QX, Chen LQ, Hu WP, Deng HY, Yuan Y, Cai J. Three-field lymph node dissection in treating the esophageal cancer. J Thorac Dis. 2016;8(10):E1136–E49.PubMedPubMedCentralCrossRef
23.
go back to reference Fujita H, Sueyoshi S, Tanaka T, Fujii T, Toh U, Mine T, et al. Optimal lymphadenectomy for squamous cell carcinoma in the thoracic esophagus: comparing the short- and long-term outcome among the four types of lymphadenectomy. World J Surg. 2003;27(5):571–9.PubMedCrossRef Fujita H, Sueyoshi S, Tanaka T, Fujii T, Toh U, Mine T, et al. Optimal lymphadenectomy for squamous cell carcinoma in the thoracic esophagus: comparing the short- and long-term outcome among the four types of lymphadenectomy. World J Surg. 2003;27(5):571–9.PubMedCrossRef
24.
go back to reference Gockel I, Sgourakis G, Lyros O, Hansen T, Lang H. Dissection of lymph node metastases in esophageal cancer. Expert Rev Anticancer Ther. 2011;11(4):571–8.PubMedCrossRef Gockel I, Sgourakis G, Lyros O, Hansen T, Lang H. Dissection of lymph node metastases in esophageal cancer. Expert Rev Anticancer Ther. 2011;11(4):571–8.PubMedCrossRef
25.
go back to reference Wu S, Zheng J, Li Y, Yu H, Shi S, Xie W, et al. A Radiomics Nomogram for the preoperative prediction of lymph node metastasis in bladder Cancer. Clin Cancer Res. 2017;23(22):6904–11.PubMedCrossRef Wu S, Zheng J, Li Y, Yu H, Shi S, Xie W, et al. A Radiomics Nomogram for the preoperative prediction of lymph node metastasis in bladder Cancer. Clin Cancer Res. 2017;23(22):6904–11.PubMedCrossRef
26.
go back to reference Han L, Zhu Y, Liu Z, Yu T, He C, Jiang W, et al. Radiomic nomogram for prediction of axillary lymph node metastasis in breast cancer. Eur Radiol. 2019;29(7):3820–9.PubMedCrossRef Han L, Zhu Y, Liu Z, Yu T, He C, Jiang W, et al. Radiomic nomogram for prediction of axillary lymph node metastasis in breast cancer. Eur Radiol. 2019;29(7):3820–9.PubMedCrossRef
Metadata
Title
Development and validation of nomograms to intraoperatively predict metastatic patterns in regional lymph nodes in patients diagnosed with esophageal cancer
Authors
Fei Zhao
Rong-Xin Lu
Jin-Yuan Liu
Jun Fan
Hao-Ran Lin
Xiao-Yu Yang
Shu-Hui You
Qian-Ge Wu
Xue-Yun Qin
Yi Liu
Fu-Xi Zhen
Jin-Hua Luo
Wei Wang
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2021
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-020-07738-9

Other articles of this Issue 1/2021

BMC Cancer 1/2021 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine